CNAM
Campbell Newman Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $724K | Sell |
1,626
-5
| -0.3% | -$2.23K | 0.06% | 97 |
|
|
2025
Q1 | $791K | Hold |
1,631
| – | – | 0.07% | 95 |
|
|
2024
Q4 | $657K | Sell |
1,631
-34
| -2% | -$13.7K | 0.05% | 98 |
|
|
2024
Q3 | $774K | Sell |
1,665
-102
| -6% | -$47.4K | 0.06% | 96 |
|
|
2024
Q2 | $828K | Sell |
1,767
-6
| -0.3% | -$2.81K | 0.07% | 95 |
|
|
2024
Q1 | $741K | Sell |
1,773
-9
| -0.5% | -$3.76K | 0.06% | 96 |
|
|
2023
Q4 | $725K | Sell |
1,782
-25
| -1% | -$10.2K | 0.06% | 95 |
|
|
2023
Q3 | $628K | Sell |
1,807
-4
| -0.2% | -$1.39K | 0.06% | 97 |
|
|
2023
Q2 | $637K | Sell |
1,811
-15
| -0.8% | -$5.28K | 0.06% | 97 |
|
|
2023
Q1 | $575K | Buy |
+1,826
| New | +$575K | 0.06% | 101 |
|